COVID-19 Impact on Global Anti-inflammatory Therapy Market Size, Status and Forecast 2020-2026

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global Anti-inflammatory Therapy Market Size Growth Rate by Type: 2020 VS 2026
  • 1.2.2 Corticosteroids
  • 1.2.3 Anti-inflammatory Biologics
  • 1.2.4 Non-Steroidal Anti-inflammatory Drugs
  • 1.2.5 Others
• 1.3 Market by Application
  • 1.3.1 Global Anti-inflammatory Therapy Market Share by Application: 2020 VS 2026
  • 1.3.2 Respiratory Diseases
  • 1.3.3 Arthritis
  • 1.3.4 Gastroenterology
  • 1.3.5 Dermatology
  • 1.3.6 Others
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global Anti-inflammatory Therapy Market Perspective (2015-2026)
• 2.2 Global Anti-inflammatory Therapy Growth Trends by Regions
  • 2.2.1 Anti-inflammatory Therapy Market Size by Regions: 2015 VS 2020 VS 2026
  • 2.2.2 Anti-inflammatory Therapy Historic Market Share by Regions (2015-2020)
  • 2.2.3 Anti-inflammatory Therapy Forecasted Market Size by Regions (2021-2026)
• 2.3 Industry Trends and Growth Strategy
  • 2.3.1 Market Trends
  • 2.3.2 Market Drivers
  • 2.3.3 Market Challenges
  • 2.3.4 Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top Anti-inflammatory Therapy Players by Market Size
  • 3.1.1 Global Top Anti-inflammatory Therapy Players by Revenue (2015-2020)
  • 3.1.2 Global Anti-inflammatory Therapy Revenue Market Share by Players (2015-2020)
• 3.2 Global Anti-inflammatory Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by Anti-inflammatory Therapy Revenue
• 3.4 Global Anti-inflammatory Therapy Market Concentration Ratio
  • 3.4.1 Global Anti-inflammatory Therapy Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by Anti-inflammatory Therapy Revenue in 2019
• 3.5 Key Players Anti-inflammatory Therapy Area Served
• 3.6 Key Players Anti-inflammatory Therapy Product Solution and Service
• 3.7 Date of Enter into Anti-inflammatory Therapy Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 Anti-inflammatory Therapy Breakdown Data by Type (2015-2026)

• 4.1 Global Anti-inflammatory Therapy Historic Market Size by Type (2015-2020)
• 4.2 Global Anti-inflammatory Therapy Forecasted Market Size by Type (2021-2026)

5 Anti-inflammatory Therapy Breakdown Data by Application (2015-2026)

• 5.1 Global Anti-inflammatory Therapy Historic Market Size by Application (2015-2020)
• 5.2 Global Anti-inflammatory Therapy Forecasted Market Size by Application (2021-2026)

6 North America

• 6.1 North America Anti-inflammatory Therapy Market Size (2015-2026)
• 6.2 North America Anti-inflammatory Therapy Market Size by Type (2015-2020)
• 6.3 North America Anti-inflammatory Therapy Market Size by Application (2015-2020)
• 6.4 North America Anti-inflammatory Therapy Market Size by Country (2015-2020)
  • 6.4.1 United States
  • 6.4.2 Canada

7 Europe

• 7.1 Europe Anti-inflammatory Therapy Market Size (2015-2026)
• 7.2 Europe Anti-inflammatory Therapy Market Size by Type (2015-2020)
• 7.3 Europe Anti-inflammatory Therapy Market Size by Application (2015-2020)
• 7.4 Europe Anti-inflammatory Therapy Market Size by Country (2015-2020)
  • 7.4.1 Germany
  • 7.4.2 France
  • 7.4.3 U.K.
  • 7.4.4 Italy
  • 7.4.5 Russia
  • 7.4.6 Nordic
  • 7.4.7 Rest of Europe

8 China

• 8.1 China Anti-inflammatory Therapy Market Size (2015-2026)
• 8.2 China Anti-inflammatory Therapy Market Size by Type (2015-2020)
• 8.3 China Anti-inflammatory Therapy Market Size by Application (2015-2020)
• 8.4 China Anti-inflammatory Therapy Market Size by Region (2015-2020)
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 South Korea
  • 8.4.4 Southeast Asia
  • 8.4.5 India
  • 8.4.6 Australia
  • 8.4.7 Rest of Asia-Pacific

9 Japan

• 9.1 Japan Anti-inflammatory Therapy Market Size (2015-2026)
• 9.2 Japan Anti-inflammatory Therapy Market Size by Type (2015-2020)
• 9.3 Japan Anti-inflammatory Therapy Market Size by Application (2015-2020)
• 9.4 Japan Anti-inflammatory Therapy Market Size by Country (2015-2020)
  • 9.4.1 Mexico
  • 9.4.2 Brazil

10 Southeast Asia

• 10.1 Southeast Asia Anti-inflammatory Therapy Market Size (2015-2026)
• 10.2 Southeast Asia Anti-inflammatory Therapy Market Size by Type (2015-2020)
• 10.3 Southeast Asia Anti-inflammatory Therapy Market Size by Application (2015-2020)
• 10.4 Southeast Asia Anti-inflammatory Therapy Market Size by Country (2015-2020)
  • 10.4.1 Turkey
  • 10.4.2 Saudi Arabia
  • 10.4.3 UAE
  • 10.4.4 Rest of Middle East & Africa

11Key Players Profiles

• 11.1 AbbVie
  • 11.1.1 AbbVie Company Details
  • 11.1.2 AbbVie Business Overview
  • 11.1.3 AbbVie Anti-inflammatory Therapy Introduction
  • 11.1.4 AbbVie Revenue in Anti-inflammatory Therapy Business (2015-2020))
  • 11.1.5 AbbVie Recent Development
• 11.2 Johnson & Johnson
  • 11.2.1 Johnson & Johnson Company Details
  • 11.2.2 Johnson & Johnson Business Overview
  • 11.2.3 Johnson & Johnson Anti-inflammatory Therapy Introduction
  • 11.2.4 Johnson & Johnson Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.2.5 Johnson & Johnson Recent Development
• 11.3 Amgen Inc
  • 11.3.1 Amgen Inc Company Details
  • 11.3.2 Amgen Inc Business Overview
  • 11.3.3 Amgen Inc Anti-inflammatory Therapy Introduction
  • 11.3.4 Amgen Inc Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.3.5 Amgen Inc Recent Development
• 11.4 AstraZeneca PLC
  • 11.4.1 AstraZeneca PLC Company Details
  • 11.4.2 AstraZeneca PLC Business Overview
  • 11.4.3 AstraZeneca PLC Anti-inflammatory Therapy Introduction
  • 11.4.4 AstraZeneca PLC Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.4.5 AstraZeneca PLC Recent Development
• 11.5 Pfizer, Inc
  • 11.5.1 Pfizer, Inc Company Details
  • 11.5.2 Pfizer, Inc Business Overview
  • 11.5.3 Pfizer, Inc Anti-inflammatory Therapy Introduction
  • 11.5.4 Pfizer, Inc Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.5.5 Pfizer, Inc Recent Development
• 11.6 Novartis
  • 11.6.1 Novartis Company Details
  • 11.6.2 Novartis Business Overview
  • 11.6.3 Novartis Anti-inflammatory Therapy Introduction
  • 11.6.4 Novartis Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.6.5 Novartis Recent Development
• 11.7 Roche
  • 11.7.1 Roche Company Details
  • 11.7.2 Roche Business Overview
  • 11.7.3 Roche Anti-inflammatory Therapy Introduction
  • 11.7.4 Roche Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.7.5 Roche Recent Development
• 11.8 Merck
  • 11.8.1 Merck Company Details
  • 11.8.2 Merck Business Overview
  • 11.8.3 Merck Anti-inflammatory Therapy Introduction
  • 11.8.4 Merck Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.8.5 Merck Recent Development
• 11.9 Sanofi
  • 11.9.1 Sanofi Company Details
  • 11.9.2 Sanofi Business Overview
  • 11.9.3 Sanofi Anti-inflammatory Therapy Introduction
  • 11.9.4 Sanofi Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.9.5 Sanofi Recent Development
• 11.10 GlaxoSmithKline
  • 11.10.1 GlaxoSmithKline Company Details
  • 11.10.2 GlaxoSmithKline Business Overview
  • 11.10.3 GlaxoSmithKline Anti-inflammatory Therapy Introduction
  • 11.10.4 GlaxoSmithKline Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 11.10.5 GlaxoSmithKline Recent Development
• 11.11 Sun Pharmaceutical Industries Ltd
  • 10.11.1 Sun Pharmaceutical Industries Ltd Company Details
  • 10.11.2 Sun Pharmaceutical Industries Ltd Business Overview
  • 10.11.3 Sun Pharmaceutical Industries Ltd Anti-inflammatory Therapy Introduction
  • 10.11.4 Sun Pharmaceutical Industries Ltd Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 10.11.5 Sun Pharmaceutical Industries Ltd Recent Development
• 11.12 TEVA
  • 10.12.1 TEVA Company Details
  • 10.12.2 TEVA Business Overview
  • 10.12.3 TEVA Anti-inflammatory Therapy Introduction
  • 10.12.4 TEVA Revenue in Anti-inflammatory Therapy Business (2015-2020)
  • 10.12.5 TEVA Recent Development

12Analyst's Viewpoints/Conclusions

13Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer